Our mission is to unite and align key diabetes stakeholders and the larger diabetes community around key
diabetes-related policy and legislative efforts in order to elevate diabetes on the national agenda.

Detection

DAA’s 2018 Advocacy Priorities. Screening for diabetes is a policy priority for the Diabetes Advocacy Alliance (DAA) because screening is the entry point for detection of prediabetes, type 2 diabetes, and gestational diabetes. (Click here for a complete list of the DAA’s 2018 Advocacy Priorities.) With screening, we can:

  • Identify adults with prediabetes, who could benefit from diabetes prevention programs.
  • Identify adults with undiagnosed diabetes, enabling them to begin treatment and care to help prevent the serious health complications of diabetes.
  • Identify women with gestational diabetes, to connect them with appropriate treatment and care for themselves and their baby.




Access & Coverage for Screening
Improving access and coverage for diabetes screening will help reduce the number of people with undiagnosed prediabetes, type 2 diabetes, and gestational diabetes which is paramount in our effort to change the trajectory of the diabetes epidemic. Promoting a consistent interpretation of the U.S. Preventive Services Task Force (USPSTF) Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus guideline and helping to implement this guideline is a priority.

To view more on DAA’s work to improve screening rates, click here.